How Are Palliative Care Cancer Populations Characterized in Randomized Controlled Trials? A Literature Review

被引:19
作者
Sigurdardottir, Katrin Ruth [1 ,2 ,3 ]
Oldervoll, Line [1 ,4 ]
Hjermstad, Marianne Jensen [1 ,5 ]
Kaasa, Stein [1 ,7 ]
Knudsen, Anne Kari [1 ,7 ]
Lohre, Erik Torbjorn [7 ]
Loge, Jon Havard [1 ,6 ]
Haugen, Dagny Faksvag [1 ,3 ]
机构
[1] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med, European Palliat Care Res Ctr, N-7006 Trondheim, Norway
[2] Haraldsplass Deaconess Hosp, Sunniva Ctr Palliat Care, Bergen, Norway
[3] Haukeland Hosp, Reg Ctr Excellence Palliat Care, N-5021 Bergen, Norway
[4] Roros Rehabil Ctr, Roros, Norway
[5] Oslo Univ Hosp, Reg Ctr Excellence Palliat Care, Oslo, Norway
[6] Oslo Univ Hosp, Natl Resource Ctr Late Effects Canc Treatment, Oslo, Norway
[7] Univ Trondheim Hosp, Dept Oncol, St Olavs Hosp, N-7006 Trondheim, Norway
关键词
Palliative care; literature review; randomized clinical trial; cancer; patient characteristic; generalizability; publication standard; basic data set; QUALITY-OF-LIFE; CELL LUNG-CANCER; PAINFUL BONE METASTASES; ND-YAG LASER; CONTROLLED-RELEASE MORPHINE; EXPANDABLE METAL STENTS; PHASE-III TRIAL; TRANSMUCOSAL FENTANYL CITRATE; MALIGNANT PLEURAL EFFUSIONS; SINGLE-DOSE BRACHYTHERAPY;
D O I
10.1016/j.jpainsymman.2013.06.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. The difficulties in defining a palliative care patient accentuate the need to provide stringent descriptions of the patient population in palliative care research. Objectives. To conduct a systematic literature review with the aim of identifying which key variables have been used to describe adult palliative care cancer populations in randomized controlled trials (RCTs). Methods. The data sources used were MEDLINE (1950 to January 25, 2010) and Embase (1980 to January 25, 2010), limited to RCTs in adult cancer patients with incurable disease. Forty-three variables were systematically extracted from the eligible articles. Results. The review includes 336 articles reporting RCTs in palliative care cancer patients. Age (98%), gender (90%), cancer diagnosis (89%), performance status (45%), and survival (45%) were the most frequently reported variables. A large number of other variables were much less frequently reported. Conclusion. A substantial variation exists in how palliative care cancer populations are described in RCTs. Few variables are consistently registered and reported. There is a clear need to standardize the reporting. The results from this work will serve as the basis for an international Delphi process with the aim of reaching consensus on a minimum set of descriptors to characterize a palliative care cancer population. (C) 2014 U. S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:906 / +
页数:26
相关论文
共 381 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Palliation of inoperable esophageal carcinoma: A prospective randomized trial of laser therapy and stent placement [J].
Adam, A ;
Ellul, J ;
Watkinson, AF ;
Tan, BS ;
Morgan, RA ;
Saunders, MP ;
Mason, RC .
RADIOLOGY, 1997, 202 (02) :344-348
[3]   Efficacy of senna versus lactulose in terminal cancer patients treated with opioids [J].
Agra, Y ;
Sacristan, A ;
Gonzalez, M ;
Ferrari, M ;
Portugues, A ;
Calvo, MJ .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 15 (01) :1-7
[4]   Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer [J].
Agteresch, HJ ;
Dagnelie, PC ;
van der Gaast, A ;
Stijnen, T ;
Wilson, JH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04) :321-328
[5]   Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma - Results of Intergroup 0159/Cancer and Leukemia Group B 9480 [J].
Ahles, TA ;
Herndon, JE ;
Small, EJ ;
Vogelzang, NJ ;
Kornblith, AB ;
Ratain, MJ ;
Stadler, W ;
Palchak, D ;
Marshall, ME ;
Wilding, G ;
Petrylak, D ;
Holland, JC .
CANCER, 2004, 101 (10) :2202-2208
[6]   Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life [J].
Ahmedzai, S ;
Brooks, D .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (05) :254-261
[7]   Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 study group [J].
Ajani, Jaffer A. ;
Moiseyenko, Vladimir M. ;
Tjulandin, Sergei ;
Majlis, Alejandro ;
Constenla, Manuel ;
Boni, Corrado ;
Rodrigues, Adriano ;
Fodor, Miguel ;
Chao, Yee ;
Voznyi, Edouard ;
Marabotti, Cindy ;
Van Cutsem, Eric .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3205-3209
[8]   LASER RECANALIZATION VERSUS ENDOSCOPIC INTUBATION IN THE PALLIATION OF MALIGNANT DYSPHAGIA [J].
ALDERSON, D ;
WRIGHT, PD .
BRITISH JOURNAL OF SURGERY, 1990, 77 (10) :1151-1153
[9]   How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial [J].
Allard, P ;
Lamontagne, C ;
Bernard, P ;
Tremblay, C .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 17 (04) :256-265
[10]  
Amouzegar-Hashemi F, 2008, CURR ONCOL, V15, P36